Research and experimental development on natural sciences and engineering
SURVIVA AS
Revenue 2024
NOK 4.8m
Operating profit
NOK 290,000
Equity
NOK 2.8m
Incorporated
2012
Share capital
NOK 116,000
Roles
Daglig lederAstrid Hilde Myrset
Regnskapsfører
Styrets lederAstrid Hilde Myrset
StyremedlemAudun Sverre Myrset Kvalvaag
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| ASTRID HILDE MYRSET | 73.8% | 85650.000000 | 2025 |
| PER VIDAR SYVERSEN | 12.0% | 13900.000000 | 2025 |
| SURVIVA AS | 2.8% | 3220.000000 | 2025 |
| AUDUN SVERRE MYRSET KVALVAAG | 2.3% | 2718.000000 | 2025 |
| ELISABETH MYRSET KVALVAAG | 2.0% | 2333.000000 | 2025 |
| LIV HILDE MYRSET BRISÅ | 1.8% | 2083.000000 | 2025 |
| ØYVIND ANDERS MYRSET SYVERSEN | 1.8% | 2083.000000 | 2025 |
| TURID KOKSVIK HØYSÆTER | 1.6% | 1808.000000 | 2025 |
| JHANSI PANGA | 1.2% | 1355.000000 | 2025 |
| STIAN HALSE AS | 0.4% | 500.000000 | 2025 |
| JOWITA SLEBODA | 0.2% | 250.000000 | 2025 |
| CATHRINE FRYDENLUND | 0.1% | 100.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| POSTR AS | Active | 29.3% | 25500.000000 |
| SURVIVA AS | Active | 2.8% | 3220.000000 |
| ALGIPHARMA HOLDING AS | Active | 0.0% | 2626.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.